Medicine & Life Sciences
SARS Virus
100%
Coronavirus
85%
Severe Acute Respiratory Syndrome
58%
proguanil drug combination atovaquone
56%
Epidemiology
53%
Human parainfluenza virus 3
52%
Cytochromes b
49%
Cambodia
47%
Child
44%
Respiratory Syncytial Virus Infections
43%
Plasmodium falciparum
35%
Respiratory Syncytial Viruses
31%
Vaccination
27%
Infections
21%
Mutation
15%
Viral Load
14%
Nose
13%
Treatment Failure
13%
dihydroorotate dehydrogenase
11%
Atovaquone
10%
Incidence
9%
Odds Ratio
8%
Clinical Trials
8%
Southeastern Asia
8%
Confidence Intervals
8%
Reverse Transcriptase Polymerase Chain Reaction
8%
Recurrence
7%
Seroepidemiologic Studies
7%
Serology
7%
Point Mutation
6%
High-Throughput Nucleotide Sequencing
6%
Epidemics
6%
Therapeutics
5%
Paramyxoviridae Infections
5%